Quan Lin

1.4k total citations
49 papers, 938 citations indexed

About

Quan Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Quan Lin has authored 49 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Quan Lin's work include Lung Cancer Treatments and Mutations (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Peptidase Inhibition and Analysis (5 papers). Quan Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Peptidase Inhibition and Analysis (5 papers). Quan Lin collaborates with scholars based in China, United States and Canada. Quan Lin's co-authors include Hesham M. Amin, Raymond Lai, George Z. Rassidakis, Yasushi Fujio, Keita Kunisada, Ioannis Grammatikakis, L. Jeffrey Medeiros, Vilmos Thomázy, Stanley R. Hamilton and Lucian R. Chirieac and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Quan Lin

45 papers receiving 922 citations

Peers

Quan Lin
Miguel Murillo Spain
Teruaki Fujishita Japan
Willie Wilson United States
Ana Sebio Spain
Liangkun You China
Kanika A. Bowen United States
Georgia Sotiropoulou‐Bonikou Greece
Dekuang Zhao United States
Steven L. Abrams United States
Miguel Murillo Spain
Quan Lin
Citations per year, relative to Quan Lin Quan Lin (= 1×) peers Miguel Murillo

Countries citing papers authored by Quan Lin

Since Specialization
Citations

This map shows the geographic impact of Quan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Lin more than expected).

Fields of papers citing papers by Quan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Lin. The network helps show where Quan Lin may publish in the future.

Co-authorship network of co-authors of Quan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Quan Lin. A scholar is included among the top collaborators of Quan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quan Lin. Quan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Ying, Quan Lin, Yanyan Jiang, et al.. (2025). Quercetin can improve anesthesia induced neuroinflammation and cognitive dysfunction by regulating miR-138-5p/ LCN2. BMC Anesthesiology. 25(1). 21–21. 1 indexed citations
2.
Qin, Shuangshuang, Ying Liang, Yan Xie, et al.. (2025). Genome-wide analysis of the bHLH gene family in Spatholobus suberectus identifies SsbHLH112 as a regulator of flavonoid biosynthesis. BMC Plant Biology. 25(1). 594–594. 1 indexed citations
3.
Xu, Xiaohao, Ning Tian, Peng‐Hui Wang, et al.. (2025). Ginsenoside Rb1 carbon nanodots: A green and promising nanomedicine for effective gastric cancer treatment. Colloids and Surfaces B Biointerfaces. 256(Pt 2). 115087–115087.
4.
Li, Xiaolu, Jinfeng Zhang, Qinghe Zhang, et al.. (2025). In situ restoration of river sediment by sediment microbial fuel cells enhanced with ecological floating islands. Journal of Soils and Sediments. 25(4). 1469–1486.
5.
Zhang, Kailun, et al.. (2025). Advances and challenges in pathomics for liver cancer: From diagnosis to prognostic stratification. World Journal of Clinical Oncology. 16(6). 107646–107646. 2 indexed citations
6.
Qin, Shuangshuang, et al.. (2024). Analysis of the Spatholobus suberectus full-length transcriptome identified an R2R3-MYB transcription factor-encoding gene SsMYB158 that regulates flavonoid biosynthesis. Plant Physiology and Biochemistry. 214. 108929–108929. 4 indexed citations
7.
Liu, Wei, et al.. (2024). Major depression disorder and heart failure: A two-sample bidirectional Mendelian randomization study. PLoS ONE. 19(5). e0304379–e0304379. 1 indexed citations
8.
Wang, Jifeng, et al.. (2024). Low toxicity ginsenoside Rg1-carbon nanodots as a potential therapeutic agent for human non-small cell lung cancer. Colloids and Surfaces B Biointerfaces. 246. 114392–114392. 6 indexed citations
9.
Qin, Shuangshuang, Wei Fan, Ying Liang, et al.. (2023). Genome-wide analysis of the R2R3-MYB gene family in Spatholobus suberectus and identification of its function in flavonoid biosynthesis. Frontiers in Plant Science. 14. 1219019–1219019. 8 indexed citations
10.
Rao, Chuangzhou, Xiaokang Wu, Ting Chen, et al.. (2022). Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation. Frontiers in Oncology. 12. 915502–915502.
11.
12.
Wu, Xiaokang, Dongqing Zhang, Mengru Shi, et al.. (2021). Successful targeting of the NRG1 fusion reveals durable response to afatinib in lung adenocarcinoma: a case report. Annals of Translational Medicine. 9(19). 1507–1507. 10 indexed citations
13.
Song, Zhengbo, Dongqing Lv, Shiqing Chen, et al.. (2021). Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study. Frontiers in Oncology. 11. 657283–657283. 10 indexed citations
14.
Lin, Quan, Haoran Zhang, Jun Qian, et al.. (2019). The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients. Journal of Translational Medicine. 17(1). 298–298. 35 indexed citations
15.
Wang, Shuai, et al.. (2019). Ropivacaine induces neurotoxicity by activating MAPK/p38 signal to upregulate Fas expression in neurogliocyte. Neuroscience Letters. 706. 7–11. 9 indexed citations
16.
Harada, Kazuto, et al.. (2017). Advanced gastric adenocarcinoma: optimizing therapy options. Expert Review of Clinical Pharmacology. 10(3). 1–9. 19 indexed citations
17.
18.
19.
Al‐Shamsi, Humaid O., Jane E. Rogers, Jeannette E. Mares, et al.. (2016). Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience. Journal of Gastrointestinal Oncology. 7(4). 499–505. 17 indexed citations
20.
Chen, Chan, Chun Chen, Zhiyi Wang, et al.. (2012). Puerarin Induces Mitochondria-Dependent Apoptosis in Hypoxic Human Pulmonary Arterial Smooth Muscle Cells. PLoS ONE. 7(3). e34181–e34181. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Murillo Breakdown of academic impact, for papers by Teruaki Fujishita Breakdown of academic impact, for papers by Willie Wilson Breakdown of academic impact, for papers by Ana Sebio Breakdown of academic impact, for papers by Liangkun You Breakdown of academic impact, for papers by Kanika A. Bowen Breakdown of academic impact, for papers by Georgia Sotiropoulou‐Bonikou Breakdown of academic impact, for papers by Dekuang Zhao Breakdown of academic impact, for papers by Steven L. Abrams
Rankless by CCL
2026